- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
极度弱势行情中，投资者可暂时观望。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有87家主力机构披露2025-06-30报告期持股数据，持仓量总计3.16亿股，占流通A股54.08%
- 波段诊断：
-
技术面诊股
诊断结果：7.0技术面打败了76%的股票
技术面评分前10的股票
近期的平均成本为15.27元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为15.27元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.27","date":1759133018,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.09.30","stock":"-0.65","trade":"0.12","ind":"0.35"},{"date":"2025.09.29","stock":"-0.19","trade":"0.13","ind":"2.05"},{"date":"2025.09.26","stock":"-0.32","trade":"-0.51","ind":"-1.76"},{"date":"2025.09.25","stock":"-0.52","trade":"-0.70","ind":"0.67"},{"date":"2025.09.24","stock":"0.32","trade":"1.12","ind":"1.80"},{"date":"2025.09.23","stock":"-0.90","trade":"-1.40","ind":"-0.29"},{"date":"2025.09.22","stock":"-0.26","trade":"-0.53","ind":"0.67"},{"date":"2025.09.19","stock":"-0.19","trade":"-1.04","ind":"-0.04"},{"date":"2025.09.18","stock":"-1.20","trade":"-1.21","ind":"-1.06"},{"date":"2025.09.17","stock":"1.02","trade":"-0.25","ind":"1.16"},{"date":"2025.09.16","stock":"0.26","trade":"0.68","ind":"0.45"},{"date":"2025.09.15","stock":"-0.06","trade":"-0.41","ind":"0.63"},{"date":"2025.09.12","stock":"-0.32","trade":"-0.31","ind":"-0.43"},{"date":"2025.09.11","stock":"0.64","trade":"0.43","ind":"3.36"},{"date":"2025.09.10","stock":"-0.95","trade":"0.02","ind":"0.38"},{"date":"2025.09.09","stock":"-0.69","trade":"-1.27","ind":"-1.23"},{"date":"2025.09.08","stock":"1.15","trade":"1.30","ind":"0.61"},{"date":"2025.09.05","stock":"0.70","trade":"1.12","ind":"3.89"},{"date":"2025.09.04","stock":"0.45","trade":"-0.37","ind":"-2.83"},{"date":"2025.09.03","stock":"-1.58","trade":"-1.55","ind":"-0.65"},{"date":"2025.09.02","stock":"-1.07","trade":"-1.12","ind":"-2.14"}]
葵花药业,深证成指,中药指数
压力支撑
该股压力位为15.28元，支撑位为15.20元。
[{"text":"\u538b\u529b\u4f4d","value":"15.28","date":1759161600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.20","date":1759161600,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.5资金面打败了29%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月02日 20:30
| 机构今日流向(万元) | -953.37 | 机构5日流向(万元) | -2503.12 |
| 机构10日流向(万元) | -13675.87 | 机构20日流向(万元) | -26570.05 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1100.69万股，其中基金净减仓7家，主力净减仓55家，请投资者中长期谨慎为宜。
截止2025-06-30，共87家主力机构（基金84家，一般法人3家），持仓量总计31583.21万股，占流通A股54.08%
其中，基金持仓与2024-12-31相比：
增仓：21家 ，增持 139.11万股
减仓：28家 ，减持 184.44万股
新出现在主力名单中：28家 ，持有239.74万股
从主力名单中消失：83家 ，原持有1255.65万股
其中，基金持仓与2024-12-31相比：
增仓：21家 ，增持 139.11万股
减仓：28家 ，减持 184.44万股
新出现在主力名单中：28家 ，持有239.74万股
从主力名单中消失：83家 ，原持有1255.65万股
消息面诊股
诊断结果：5.4消息面打败了22%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 葵花药业：9月29日获融资买入726.97万元
2025-09-30 - 葵花药业（截止2025年9月20日）股东人数为53
2025-09-29 - 葵花药业：9月26日获融资买入503.87万元
2025-09-29 - 行业追踪|中医药市场（9月22日-9月28日）：综
2025-09-28 - 葵花药业：9月25日获融资买入871.67万元
2025-09-26 - 葵花药业：9月24日获融资买入324.06万元
2025-09-25 - 葵花药业：公司目前产品以中成药为主，未来将通过“买
2025-09-25 - 葵花药业：9月23日获融资买入1075.13万元
2025-09-24 - 葵花药业：9月22日获融资买入931.81万元
2025-09-23 - 葵花药业：9月19日获融资买入1248.43万元
2025-09-22
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-08-20 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-07-26 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-07-12 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-07-09 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 高管变动 | 因退休原因 | 2025-06-24 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-25 |
| 利好 | 分红转增 | 10派5元(含税) | 2025-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-25 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-18 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-01-08 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 高管变动 | 因个人退休原因 | 2024-10-07 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 2条 | 2条 | 0条 |
行业面诊股
诊断结果：1.8行业面打败了22%的股票
中药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.09.30","price":"0.35","value":"0.12"},{"date":"2025.09.29","price":"2.05","value":"0.13"},{"date":"2025.09.26","price":"-1.76","value":"-0.51"},{"date":"2025.09.25","price":"0.67","value":"-0.70"},{"date":"2025.09.24","price":"1.80","value":"1.12"},{"date":"2025.09.23","price":"-0.29","value":"-1.40"},{"date":"2025.09.22","price":"0.67","value":"-0.53"},{"date":"2025.09.19","price":"-0.04","value":"-1.04"},{"date":"2025.09.18","price":"-1.06","value":"-1.21"},{"date":"2025.09.17","price":"1.16","value":"-0.25"},{"date":"2025.09.16","price":"0.45","value":"0.68"},{"date":"2025.09.15","price":"0.63","value":"-0.41"},{"date":"2025.09.12","price":"-0.43","value":"-0.31"},{"date":"2025.09.11","price":"3.36","value":"0.43"},{"date":"2025.09.10","price":"0.38","value":"0.02"},{"date":"2025.09.09","price":"-1.23","value":"-1.27"},{"date":"2025.09.08","price":"0.61","value":"1.30"},{"date":"2025.09.05","price":"3.89","value":"1.12"},{"date":"2025.09.04","price":"-2.83","value":"-0.37"},{"date":"2025.09.03","price":"-0.65","value":"-1.55"},{"date":"2025.09.02","price":"-2.14","value":"-1.12"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 403.78% | 6.58% | 6.4分 |
| 2 | 佛慈制药 | 174.20% | -1.37% | 5.9分 |
| 3 | 方盛制药 | 5.00% | 4.45% | 6.2分 |
| 4 | - | 4.39% | 4.39% | 分 |
| 5 | 信邦制药 | 3.83% | 11.11% | 6.3分 |
| 6 | 吉林敖东 | 1.83% | 7.12% | 5.9分 |
| 8 | 江中药业 | 0.32% | 1.25% | 5.9分 |
| 10 | 贵州三力 | 0.24% | -0.78% | 5.2分 |
| 12 | 金花股份 | -0.40% | 6.92% | 6.3分 |
| 14 | 昆药集团 | -1.13% | -0.78% | 4.7分 |
| 16 | 马应龙 | -1.96% | -1.23% | 5.5分 |
| 18 | 桂林三金 | -2.47% | 0.41% | 6.3分 |
| 20 | 嘉应制药 | -3.13% | 0.98% | 5.5分 |
| 22 | 葵花药业 | -3.29% | -1.36% | 4.9分 |
| 24 | 益盛药业 | -3.47% | 1.17% | 5.0分 |
| 26 | 康恩贝 | -3.55% | -0.23% | 5.4分 |
| 28 | 佐力药业 | -3.89% | 1.37% | 5.4分 |
| 30 | 健民集团 | -4.02% | -1.10% | 5.5分 |
| 32 | 奇正藏药 | -4.17% | 0.54% | 6.0分 |
| 34 | 寿仙谷 | -4.49% | -1.30% | 5.2分 |
| 36 | 沃华医药 | -4.59% | 0.65% | 6.0分 |
| 38 | 特一药业 | -4.65% | 1.18% | 5.8分 |
| 40 | 步长制药 | -4.79% | 1.35% | 5.7分 |
| 42 | 羚锐制药 | -4.98% | -0.81% | 5.6分 |
| 44 | ST葫芦娃 | -5.16% | 0.11% | 4.4分 |
| 46 | 广誉远 | -5.44% | -0.11% | 6.0分 |
| 48 | 华神科技 | -5.71% | 0.80% | 5.5分 |
| 50 | 汉森制药 | -5.78% | 0.00% | 5.1分 |
| 52 | 华润三九 | -6.30% | 0.00% | 5.7分 |
| 54 | 仁和药业 | -6.51% | -3.83% | 4.8分 |
| 56 | 千金药业 | -6.53% | -0.77% | 5.7分 |
| 58 | 亚宝药业 | -6.84% | 0.62% | 5.6分 |
| 60 | 达仁堂 | -7.27% | -1.25% | 5.3分 |
| 62 | 太龙药业 | -7.29% | 2.53% | 5.7分 |
| 64 | 九芝堂 | -12.35% | -2.41% | 4.9分 |
| 66 | 新天药业 | -12.59% | -0.65% | 4.8分 |
| 68 | 众生药业 | -17.75% | -3.19% | 5.1分 |
| 70 | 振东制药 | -23.72% | -7.34% | 4.4分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 45/112 ， 52/112。
[{"date":"2025-06-30","value":"1.84","vol":"3.94"},{"date":"2025-03-31","value":"1.30","vol":"2.20"},{"date":"2024-12-31","value":"10.76","vol":"4.81"},{"date":"2024-09-30","value":"12.70","vol":"2.92"},{"date":"2024-06-30","value":"10.64","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.84 | 1.30 | 10.76 | 12.70 | 10.64 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"38.85","vol":"52.43"},{"date":"2025-03-31","value":"37.29","vol":"52.92"},{"date":"2024-12-31","value":"44.89","vol":"52.40"},{"date":"2024-09-30","value":"52.23","vol":"52.75"},{"date":"2024-06-30","value":"55.70","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
38.85 | 37.29 | 44.89 | 52.23 | 55.70 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 66/112 ， 62/112。
[{"date":"2025-06-30","value":"-48.17","vol":"-6.98"},{"date":"2025-03-31","value":"-56.30","vol":"-6.63"},{"date":"2024-12-31","value":"-40.76","vol":"-6.97"},{"date":"2024-09-30","value":"-29.95","vol":"-4.57"},{"date":"2024-06-30","value":"-16.69","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-48.17 | -56.30 | -40.76 | -29.95 | -16.69 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-83.28","vol":"2.33"},{"date":"2025-03-31","value":"-77.62","vol":"-36.42"},{"date":"2024-12-31","value":"-56.03","vol":"-142.71"},{"date":"2024-09-30","value":"-31.06","vol":"63.06"},{"date":"2024-06-30","value":"-23.79","vol":"-13.81"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-83.28 | -77.62 | -56.03 | -31.06 | -23.79 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.81 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 38/112 ， 36/112。
[{"date":"2025-06-30","value":"0.23","vol":"0.24"},{"date":"2025-03-31","value":"0.11","vol":"0.12"},{"date":"2024-12-31","value":"0.53","vol":"0.49"},{"date":"2024-09-30","value":"0.46","vol":"0.37"},{"date":"2024-06-30","value":"0.38","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.23 | 0.11 | 0.53 | 0.46 | 0.38 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.99","vol":"1.17"},{"date":"2025-03-31","value":"0.50","vol":"0.60"},{"date":"2024-12-31","value":"2.14","vol":"2.40"},{"date":"2024-09-30","value":"1.57","vol":"1.79"},{"date":"2024-06-30","value":"1.26","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.99 | 0.50 | 2.14 | 1.57 | 1.26 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 12/112 ， 12/112。
[{"date":"2025-06-30","value":"38.34","vol":"20.17"},{"date":"2025-03-31","value":"15.33","vol":"0.38"},{"date":"2024-12-31","value":"22.36","vol":"15.45"},{"date":"2024-09-30","value":"-58.50","vol":"6.15"},{"date":"2024-06-30","value":"-34.32","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 38.34 | 15.33 | 22.36 | -58.50 | -34.32 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.24","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.50","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.56","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.24 | - | 0.50 | - | 0.56 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 62/112 ， 59/112。
[{"date":"2025-06-30","value":"4.44","vol":"2.88"},{"date":"2025-03-31","value":"4.15","vol":"2.97"},{"date":"2024-12-31","value":"3.78","vol":"2.86"},{"date":"2024-09-30","value":"4.00","vol":"3.22"},{"date":"2024-06-30","value":"3.28","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.44 | 4.15 | 3.78 | 4.00 | 3.28 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.45","vol":"2.11"},{"date":"2025-03-31","value":"3.18","vol":"2.20"},{"date":"2024-12-31","value":"2.82","vol":"2.09"},{"date":"2024-09-30","value":"2.89","vol":"2.40"},{"date":"2024-06-30","value":"2.45","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.45 | 3.18 | 2.82 | 2.89 | 2.45 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 58/112 ， 57/112。
[{"date":"2025-06-30","value":"18.32","vol":"33.91"},{"date":"2025-03-31","value":"19.49","vol":"33.34"},{"date":"2024-12-31","value":"21.21","vol":"34.08"},{"date":"2024-09-30","value":"20.79","vol":"32.93"},{"date":"2024-06-30","value":"26.28","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
18.32 | 19.49 | 21.21 | 20.79 | 26.28 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.23","vol":"0.74"},{"date":"2025-03-31","value":"0.25","vol":"0.72"},{"date":"2024-12-31","value":"0.28","vol":"0.74"},{"date":"2024-09-30","value":"0.28","vol":"3.16"},{"date":"2024-06-30","value":"0.38","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.23 | 0.25 | 0.28 | 0.28 | 0.38 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"7.05","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.67","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.19","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"4.92","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.02","blueLineValue":"0.86","type":"YC"}]